CellaVision AB
STO:CEVI
CellaVision AB
Operating Expenses
CellaVision AB
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Operating Expenses
-kr309.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-12%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Operating Expenses
-kr4.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Operating Expenses
-kr453.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Operating Expenses
-kr12.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Operating Expenses
-kr3.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Operating Expenses
-kr180.7m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-20%
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's Operating Expenses?
Operating Expenses
-309.4m
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Operating Expenses amounts to -309.4m SEK.
What is CellaVision AB's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-12%
Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for CellaVision AB have been -10% over the past three years , -8% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet